1. Home
  2. CLGN vs LITB Comparison

CLGN vs LITB Comparison

Compare CLGN & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • LITB
  • Stock Information
  • Founded
  • CLGN 2004
  • LITB 2007
  • Country
  • CLGN Israel
  • LITB Singapore
  • Employees
  • CLGN N/A
  • LITB N/A
  • Industry
  • CLGN Industrial Specialties
  • LITB Catalog/Specialty Distribution
  • Sector
  • CLGN Health Care
  • LITB Consumer Discretionary
  • Exchange
  • CLGN Nasdaq
  • LITB Nasdaq
  • Market Cap
  • CLGN 33.8M
  • LITB 36.4M
  • IPO Year
  • CLGN N/A
  • LITB N/A
  • Fundamental
  • Price
  • CLGN $2.23
  • LITB $1.97
  • Analyst Decision
  • CLGN Strong Buy
  • LITB
  • Analyst Count
  • CLGN 2
  • LITB 0
  • Target Price
  • CLGN $11.50
  • LITB N/A
  • AVG Volume (30 Days)
  • CLGN 250.5K
  • LITB 34.4K
  • Earning Date
  • CLGN 11-26-2025
  • LITB 09-09-2025
  • Dividend Yield
  • CLGN N/A
  • LITB N/A
  • EPS Growth
  • CLGN N/A
  • LITB N/A
  • EPS
  • CLGN N/A
  • LITB 0.12
  • Revenue
  • CLGN $2,402,000.00
  • LITB $220,656,000.00
  • Revenue This Year
  • CLGN $1,617.28
  • LITB N/A
  • Revenue Next Year
  • CLGN $83.54
  • LITB N/A
  • P/E Ratio
  • CLGN N/A
  • LITB $16.88
  • Revenue Growth
  • CLGN 248.62
  • LITB N/A
  • 52 Week Low
  • CLGN $1.31
  • LITB $0.91
  • 52 Week High
  • CLGN $4.99
  • LITB $2.80
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 40.00
  • LITB 56.85
  • Support Level
  • CLGN $2.21
  • LITB $1.92
  • Resistance Level
  • CLGN $3.18
  • LITB $2.15
  • Average True Range (ATR)
  • CLGN 0.22
  • LITB 0.15
  • MACD
  • CLGN -0.06
  • LITB -0.03
  • Stochastic Oscillator
  • CLGN 6.00
  • LITB 27.27

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: